Universitätsklinikum Frankfurt am Main (KGU)

Advancing CNS tumor diagnostics with expanded DNA methylation-based classification (2026) Sill M, Schrimpf D, Patel A, Sturm D, Jäger N, Sievers P, Schweizer L, et al. Journal article PRDM16 expression is an independent prognostic factor in AML with the double-mutant NPM1/FLT3-ITD genotype (2026) Stasik S, Eckardt JN, Röllig C, Baldus CD, Serve H, Müller-Tidow C, Schäfer-Eckart K, et al. Journal article RT-PCR–Based Detection of Bone Marrow Involvement in Ewing Sarcoma: Diagnostic Validity and Prognostic Relevance (2026) Pham T, Ranft A, Rechl V, Jabar S, Hartmann W, Falkenberg K, Jürgens H, et al. Journal article Rare genetic variants confer a high risk of ADHD and implicate neuronal biology (2026) Demontis D, Duan J, Hsu YHH, Pintacuda G, Grove J, Nielsen TT, Thirstrup J, et al. Journal article Tisagenlecleucel for post-transplant relapse in young acute lymphoblastic leukemia patients: European real-world determinants of outcome (2026) Moser LM, Hutter M, Ahlmann M, Alonso-Saladrigues A, Attarbaschi A, Ayuk FA, Baldus CD, et al. Journal article Sustainability in urology: from vision to implementation: Results from a member survey conducted by the German Society of Urology Nachhaltigkeit in der Urologie: Vom Anspruch zur Umsetzung: Ergebnisse einer Mitgliederbefragung der Deutschen Gesellschaft für Urologie e. V. (2026) Thöne M, Wullich B, Heinrichs A, Siech C, Eggersmann C, Ahlers M Journal article Patient treatment needs in atopic dermatitis: A real-world cohort study (2026) Ludemann K, Traidl S, Cornelius A, Naim J, Heratizadeh A, Honstein T, Kind B, et al. Journal article Fumarate hydratase-deficient renal cell carcinoma – results of the exploratory analysis in the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first line treatment (2026) Ahrens M, Haanen J, Albiges L, Goupil MG, Boleti E, Gravis G, Fléchon A, et al. Journal article What is the best path towards allogeneic transplantation in MDS and AML? A survey among German-spreaking centers for allogeneic hematopoietic stem cell transplantation. (2026) Krause S, Bethge W, Bug G, Elmaagacli A, Jost E, Klein SA, Kobbe G, et al. Journal article IDH2 clonal hematopoiesis and IKAROS loss cooperate in a B-ALL subtype after lenalidomide therapy for multiple myeloma (2026) Horns JM, Beder T, Künstner A, Barz MJ, Bendig S, Bozzetti C, Chitadze G, et al. Journal article